MPX Issues Response to Arizona Court of Appeals Decision

Cannabis Investing News

MPX Bioceutical Corporation issued a statement in response to a decision from the Arizona Court of Appeals.

MPX Bioceutical Corporation (CSE:MPX) issued a statement in response to a decision from the Arizona Court of Appeals.

As quoted in the press release:

MPX concurs with the views expressed in the dissenting opinion and remains committed to compliance with the AMMA by the Health for Life and The Holistic Group dispensaries. Unless and until the Jones ruling is stayed or overturned, the AMMA will not immunize patients from criminal prosecution for possession of, and thereby denied access to medicines necessary for their health and well-being.

MPX finds it inconceivable that the Arizona legislators or the public, which clearly reflected in the AMMA a determination that the medical benefits of marijuana should be available to Arizona citizens without fear of prosecution, could have intended that children with epilepsy “smoke a joint”. The intent of the AMMA, was to protect from prosecution patients utilizing marijuana or cannabis for their medicinal needs. This most recent court ruling is in direct conflict of this protection afforded by the AMMA.

The Company believes the ruling will likely be met with an appeal or other legal action which will hopefully resolve once and for all an issue that has been the subject of contention, and conflicting court rulings, for several years going back to at least 2012.

Click here to read the full press release.

Source: globenewswire.com

The Conversation (0)
×